Skip Navigation

Cardiovascular Research 2005 65(2):419-427; doi:10.1016/j.cardiores.2004.10.006
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Nahrendorf, M.
Right arrow Articles by Neubauer, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nahrendorf, M.
Right arrow Articles by Neubauer, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2004, European Society of Cardiology

Creatine kinase knockout mice show left ventricular hypertrophy and dilatation, but unaltered remodeling post-myocardial infarction

Matthias Nahrendorfa,b,1, Matthias Spindlera,1,*, Kai Hua, Lisa Bauera, Oliver Rittera, Peter Nordbecka, Thomas Quaschninga, Karl-Heinz Hillerb, Julie Wallisc, Georg Ertla, Wolfgang R. Bauera and Stefan Neubauerc

aMedizinische Universitätsklinik Würzburg, Universität Würzburg, Josef Schneider Str. 2, 97080 Würzburg, Germany
bPhysikalisches Institut (EP5), Universität Würzburg, Am Hubland, 97074 Würzburg, Germany
cDepartment of Cardiovascular Medicine, John Radcliffe Hospital, Oxford University, UK

* Corresponding author. Tel.: +49 931 2010; fax: +49 931 20136664. Email address: Spindler_M{at}medizin.uni-wuerzburg.de

Objective: Creatine kinase (CK) is responsible for the transport of high-energy phosphates in excitable tissue and is of central importance in myocardial energy homeostasis. Significant changes in myocardial energetics have been reported in mice lacking the various CK isoenzymes. Our hypothesis was that ablation of CK isoenzymes leads to cardiac hypertrophy, impaired function, and aggravation of left ventricular remodeling post-myocardial infarction.

Methods: CK-deficient mice (CK KO) were examined by cardiac magnetic resonance imaging (MRI) to determine left ventricular volumes, ejection fraction, and mass: ten wild-type (WT), 6 mitochondrial CK KO (Mito-CK–/–), 10 cytosolic CK KO (M-CK–/–), and 10 mice with combined KO (M/Mito-CK–/–).

Results: While ejection fraction was similar in all groups, there was significant LV dilatation with a ~30% increase in LV end-diastolic volumes in Mito-CK–/– and in M/Mito-CK–/–. Compared to WT, there was a striking 73% and 64% increase of LV mass in Mito-CK–/– and in M/Mito-CK–/– mice, respectively, but no significant increase of LV mass (+33%; p=n.s.) in M-CK–/–. Furthermore, significant re-expression of β-MHC, a marker of myocardial hypertrophy, was found in all CK-deficient hearts. LV remodeling was investigated by MRI in hearts of 7 WT and 10 M/Mito-CK–/– mice 4 weeks postmyocardial infarction (MI). Four weeks post-LAD ligation (MI size ~32%), WT and M/Mito-CK–/– showed a similar degree of cardiac dysfunction, dilatation, and hypertrophy.

Conclusion: Mito-CK–/– and M/Mito-CK–/– mice show significant LV dilatation and marked LV hypertrophy, but LV remodeling post-MI is not aggravated. CK ablation leads to substantial adaptational changes in heart.

KEYWORDS Energy metabolism; Hypertrophy; NMR; Remodeling; Transgenic animal models


1 Joint first authors who have contributed equally to this work.

Time for primary review 24 days


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Circ Cardiovasc GenetHome page
M. Mayr
Metabolomics: Ready for the Prime Time?
Circ Cardiovasc Genet, October 1, 2008; 1(1): 58 - 65.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
O. J. Kemi, M. A. Hoydal, P. M. Haram, A. Garnier, D. Fortin, R. Ventura-Clapier, and O. Ellingsen
Exercise training restores aerobic capacity and energy transfer systems in heart failure treated with losartan
Cardiovasc Res, October 1, 2007; 76(1): 91 - 99.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
S. Neubauer
The Failing Heart -- An Engine Out of Fuel
N. Engl. J. Med., March 15, 2007; 356(11): 1140 - 1151.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. N. Mazzadi, X. Andre-Fouet, N. Costes, P. Croisille, D. Revel, and M. F. Janier
Mechanisms leading to reversible mechanical dysfunction in severe CAD: alternatives to myocardial stunning
Am J Physiol Heart Circ Physiol, December 1, 2006; 291(6): H2570 - H2582.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. E. Cullen, A. H.Y. Yuen, L. E. Felkin, R. T. Smolenski, J. L. Hall, S. Grindle, L. W. Miller, E. J. Birks, M. H. Yacoub, and P. J.R. Barton
Myocardial Expression of the Arginine:Glycine Amidinotransferase Gene Is Elevated in Heart Failure and Normalized After Recovery: Potential Implications for Local Creatine Synthesis
Circulation, July 4, 2006; 114(1_suppl): I-16 - I-20.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Nahrendorf, J. U. Streif, K.-H. Hiller, K. Hu, P. Nordbeck, O. Ritter, D. Sosnovik, L. Bauer, S. Neubauer, P. M. Jakob, et al.
Multimodal functional cardiac MRI in creatine kinase-deficient mice reveals subtle abnormalities in myocardial perfusion and mechanics
Am J Physiol Heart Circ Physiol, June 1, 2006; 290(6): H2516 - H2521.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
V. Saks, P. Dzeja, U. Schlattner, M. Vendelin, A. Terzic, and T. Wallimann
Cardiac system bioenergetics: metabolic basis of the Frank-Starling law
J. Physiol., March 1, 2006; 571(2): 253 - 273.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. Wallis, C. A. Lygate, A. Fischer, M. ten Hove, J. E. Schneider, L. Sebag-Montefiore, D. Dawson, K. Hulbert, W. Zhang, M. H. Zhang, et al.
Supranormal Myocardial Creatine and Phosphocreatine Concentrations Lead to Cardiac Hypertrophy and Heart Failure: Insights From Creatine Transporter-Overexpressing Transgenic Mice
Circulation, November 15, 2005; 112(20): 3131 - 3139.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
I. Momken, P. Lechene, N. Koulmann, D. Fortin, P. Mateo, B. T. Doan, J. Hoerter, X. Bigard, V. Veksler, and R. Ventura-Clapier
Impaired voluntary running capacity of creatine kinase-deficient mice
J. Physiol., June 15, 2005; 565(3): 951 - 964.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. ten Hove, C. A. Lygate, A. Fischer, J. E. Schneider, A. E. Sang, K. Hulbert, L. Sebag-Montefiore, H. Watkins, K. Clarke, D. Isbrandt, et al.
Reduced Inotropic Reserve and Increased Susceptibility to Cardiac Ischemia/Reperfusion Injury in Phosphocreatine-Deficient Guanidinoacetate-N-Methyltransferase-Knockout Mice
Circulation, May 17, 2005; 111(19): 2477 - 2485.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.